TIMOTHY LAZAREK: Open Payments
NPI 1891881215 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,359 in 128 payments from 13 companies in 2025. Trend: 2023 $10,116 · 2024 $7,546 · 2025 $3,359
Food & beverage: $3,359
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 23 | $587 |
| ABBVIE INC. | 32 | $586 |
| Janssen Biotech, Inc. | 9 | $458 |
| Amgen Inc. | 14 | $357 |
| ANI Pharmaceuticals, Inc. | 12 | $291 |
| Mallinckrodt Hospital Products Inc. | 7 | $193 |
| Lilly USA, LLC | 5 | $192 |
| Novartis Pharmaceuticals Corporation | 9 | $153 |
| Aurinia Pharma U.S., Inc. | 2 | $152 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $151 |
Products named: Bimzelx, TREMFYA, RINVOQ, PURIFIED CORTROPHIN GEL, SKYRIZI, Otezla, ACTHAR, LUPKYNIS.
Industry payments across CA — which companies pay providers there.
